SMTL ID : 8bo3.1

COAGULATION FACTOR XI PROTEASE DOMAIN IN COMPLEX WITH ACTIVE SITE INHIBITOR Asundexian

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.84 Å

Oligo State

monomer

Ligands

1 x QV3: 4-[[(2~{S})-2-[4-[5-chloranyl-2-[4-(trifluoromethyl)-1,2,3-triazol-1-yl]phenyl]-5-methoxy-2-oxidanylidene-pyridin-1-yl]butanoyl]amino]-2-fluoranyl-benzamide(Non-covalent)

QV3.1: 24 residues within 4Å: Chain A: R.26, H.27, L.28, H.44, Y.134, L.137, I.141, D.182, A.183, C.184, K.185, G.186, D.187, S.188, T.206, S.207, W.208, G.209, E.210, G.211, C.212, G.219, V.220, Y.221 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:I.141, A:K.185, A:T.206 Hydrogen bonds: A:R.26, A:Y.134, A:Y.134, A:G.186, A:D.187, A:S.188, A:G.209 Water bridges: A:L.28, A:L.28, A:S.188

1 x CIT: CITRIC ACID(Non-functional Binders)

CIT.2: 4 residues within 4Å: Chain A: Q.84, Y.92, H.169, K.170 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:Q.84, A:Y.92, A:K.170 Salt bridges: A:H.169, A:H.169, A:K.170, A:K.170, A:K.170

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Roehrig, S. et al., Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders. J.Med.Chem. (2023)

Release Date

2023-09-13

Peptides

Coagulation factor XIa light chain: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
AAA

Coagulation factor XIa light chain

Related Entries With Identical Sequence